An overview of contemporary approaches to antiarrhythmic therapy

Japanese Circulation Journal

Volumn 63, Issue 9, 1999, Pages 655-658

  Roden, Dan M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arrhythmia; Clinical trials; Ion channels

Indexed keywords

ACETYLSALICYLIC ACID; AJMALICINE; AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIGOXIN; DOFETILIDE; FLECAINIDE; ISOPRENALINE; PHENYTOIN; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SOTALOL; WARFARIN;

DEFIBRILLATOR; ELECTROSURGERY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART VENTRICLE EXTRASYSTOLE; HUMAN; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; REVIEW;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; BIOMEDICAL ENGINEERING; CATHETER ABLATION; HUMANS;

EID: 0032834281     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.63.655     Document Type: Review

References (41)

1. Wallace AG, Sealy WC, Gallagher JJ, Svenson RH, Strauss HC, Kasell J: Surgical correction of anomalous left ventricular pre-excitation: Wolff-Parkinson-White (type A). Circulation 1974; 49: 206-213
2. Gallagher JJ, Svenson RH, Kasell JH, German LD, Bardy GH, Broughton, et al: Catheter technique for closed-chest ablation of the atrioventricular conduction system. N Engl J Med 1982; 306: 194-200
3. Weber H, Schmitz L: Catheter technique for closed-chest ablation of an accessory atrioventricular pathway. N Engl J Med 1983; 308: 653-654
4. Jackman WM, Friday KJ, Scherlag BJ, Dehning MM, Schechter E, Reynolds, et al: Direct endocardial recording from an accessory atrioventricular pathway: localization of the site of block, effect of antiarrhythmic drugs, and attempt at nonsurgical ablation. Circulation 1983; 68: 906-916
5. Morady F, Scheinman MM: Transvenous catheter ablation of a posteroseptal accessory pathway in a patient with the Wolff-Parkinson-White syndrome. N Engl J Med 1984; 310: 705-707
6. Touboul P, Saoudi N, Atallah G, Kirkorian G: Electrophysiologic basis of catheter ablation in atrial flutter. Am J Cardiol 1989; 64: 79J-82J
7. Saoudi N, Atallah G, Kirkorian G, Touboul P: Catheter ablation of the atrial myocardium in human type I atrial flutter. Circulation 1990; 81: 762-771
8. Epstein LM, Scheinman MM, Langberg JJ, Chilson D, Goldberg HR, Griffin JC: Percutaneous catheter modification of the atrioventricular node: A potential cure for atrioventricular nodal reentrant tachycardia. Circulation 1989; 80: 757-768
9. Haissaguerre M, Warin JF, Lemetayer P, Saoudi N, Guillem JP, Blanchot P: Closed-chest ablation of retrograde conduction in patients with atrioventricular nodal reentrant tachycardia. N Engl J Med 1989; 320: 426-433
10. Fitzgerald DM, Friday KJ, Wah JA, Lazzara R, Jackman WM: Electrogram patterns predicting successful catheter ablation of ventricular tachycardia. Circulation 1988; 77: 806-814
11. Morady F, Frank R, Kou WH, Tonet JL, Nelson SD, Kounde S, et al: Identification and catheter ablation of a zone of slow conduction in the reentrant circuit of ventricular tachycardia in humans. J Am Coll Cardiol 1988; 11: 775-782
12. Morady F: Radio-frequency ablation as treatment for cardiac arrhythmias. N Engl J Med 1999; 340: 534-544
13. The CAST Investigators: Preliminary Report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321: 406-412
14. Morady F, Kadish AH, DiCarlo L, Kou WH, Winston S, deBuitlier M, et al: Long-term results of catheter ablation of idiopathic right ventricular tachycardia. Circulation 1990; 82: 2093-2099
15. Wolfe CL, Nibley C, Bhandari A, Chatterjee K, Scheinman M: Polymorphous ventricular tachycardia associated with acute myocardial infarction. Circulation 1991; 84: 1543-1551
16. Caceres J, Jazayeri M, McKinnie J, Avitall B, Denker ST, Tchou P, et al: Sustained bundle branch reentry as a mechanism of clinical tachycardia. Circulation 1989; 79: 256-270
17. Roden DM, Lazzara R, Rosen MR, Schwartz PJ, Towbin JA, Vincent GM, et al: Multiple mechanisms in the long QT syndrome: Current knowledge, gaps, and future directions. Circulation 1996; 94: 1996-2012
18. + channel blockade and to increases in heart rate: Implications for gene-specific therapy. Circulation 1995; 92: 3381-3386
19. Priori SG, Napolitano C, Schwartz PJ: Low penetrance in the long-QT syndrome: clinical impact. Circulation 1999; 99: 529-533
20. Napolitano C, Priori SG, Schwartz PJ, Canlu F, Paganini V, Matteo PS, et al: Identification of a long QT syndrome molecular defect in drug-induced Torsades de Pointes. Circulation 1997; 96: 1-211
21. Schulze-Bahr E, Haverkamp W, Hordt M, Wedekind H, Borggrefe M, Funke H: Do mutations in cardiac ion channel genes predispose to drug-induced (acquired) long QT syndrome? Circulation 1997; 96: 1-211
22. Donger C, Denjoy I, Berthet M, Neyroud N, Cruaud C, Bennaceur M, et al: KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation 1997; 96: 2778-2781
23. Abbott GW, Sesti F, Splawski I, Buck ME, Lehmann MH, Timothy KW, et al: MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999; 97: 175-187
24. Martini B, Nava A, Thiene G, Buja GF, Canciani B, Scognamiglio R, et al: Ventricular fibrillation without apparent heart disease: description of six cases. Am Heart J 1989; 118: 1203-1209
25. Brugada P, Brugada J: Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: A multicenter report. J Am Coll Cardiol 1992; 20: 1391-1396
26. Nademanee K, Veerakul G, Nimmannit S, Chaowakul V, Bhuripanyo K, Likittanasombal K, et al: Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997; 96: 2595-2600
27. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S: Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27: 1061-1070
28. Roden DM, Wilde AA: Drug-induced J point elevation: a marker for genetic risk of sudden death or ECG curiosity? J Cardiovasc Electrophysiol 1999; 10: 219-223
29. Krishnan SC, Antzelevitch C: Flecainide-induced arrhythmia in canine ventricular epicardium: Phase 2 reentry? Circulation 1993; 87: 562-572
30. Lukas A, Antzelevitch C: Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia: Role of the transient outward current. Circulation 1993; 88: 2903-2915
31. Chen QY, Kirsch GE, Zhang DM, Brugada R, Brugada J, Brugada P, et al: Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392: 293-296
32. Jais P, Haissaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, et al: A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997; 95: 572-576
33. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666
34. Cox JL, Boineau JP, Schuessler RB, Jaquiss RDB, Lappas DG: Modification of the maze procedure for atrial flutter and atrial fibrillation .1. Rationale and surgical results. J Thorac Cardiovasc Surg 1995; 110: 473-484
35. Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont, et al: Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997; 336: 905-911
36. Mcanulty J, Halperin B, Kron J, Larsen G, Raitt M, Swenson R, et al: A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997; 337: 1576-1583
37. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996; 335: 1933-1940
38. Friedman PL, Stevenson WG: Unsustained ventricular tachycardia: To treat or not to treat. N Engl J Med 1996; 335: 1984-1985
39. Singer DE: Anticoagulation for atrial fibrillation: epidemiology informing a difficult clinical decision. Proc Assoc Am Physicians 1996; 108: 29-36
40. Waldo AL, Camm AJ, DeRuyter H, Friedman PL, MacNeil DJ, Pitt B, et al: Survival with oral d-Sotalol in patients with left ventricular dysfunction after myocardial infarction: Rationale, design, and methods (the SWORD trial). Am J Cardiol 1995; 75: 1023-1027
41. Wyse DG, Anderson JL, Antman EM, Cooper ES, Dalquist JE, Davis KB, et al: Atrial fibrillation follow-up investigation of rhythm management: The AFFIRM study design. Am J Cardiol 1997; 79: 1198-1202